一 | (ECNS) -- Across China this summer, primary and secondary school students have taken over the kitchen, preparing meals for their parents after work in a heartwarming family routine. In Ningbo, Chen Silin, a vocational high school student, spends two to three hours daily cooking lunch or dinner. Inspired by his mother's casual requests, he has learned to prepare complex dishes, building on skills he first developed in fourth grade. "I love tinkering in the kitchen," he said. "Every day feels fulfilling and rewarding." His interest in cooking began in fourth grade. "My mom's cooking was simple – mostly steaming," he said. "I wanted more variety, so I started learning on my own." With many relatives working as professional cooks, he would observe them at family gatherings and ask for tips. In Yuyao, fifth‑grader Cao Xuanrui has taken charge of family breakfasts, rotating between sandwiches, wontons and dumplings, while experimenting with new recipes. "Exploring food is so much fun — every day brings a new expectation," he said, adding that his next goal is Korean fried chicken. Du Qianle, a fifth‑grader in Ningbo, treats cooking like handicrafts, learning from online videos and preparing dishes three times a week. Her debut dish — scrambled eggs with tomatoes — won praise from guests. Since then, she has expanded to egg tarts, potato cakes and stir‑fried beef. "Mum's dishes are still better," she admitted modestly. Parents say the children's enthusiasm has transformed kitchens into spaces of creativity and bonding. For many families, the meals symbolize not just nourishment but the joy of shared effort and discovery. (By Zhang Dongfang) 
。 (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed. China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval. A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country. Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category. This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading. At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly. To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong. The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions. In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total. (By Tang Yuxian) 。
Current article:http://rnd3m3y.cuozubeishenjingli.cfd/list_wbni/634lpw.html
Published on:00:26:54
